The Niche

2 FDA warnings to perinatal firms including Platinum Biologics paradoxically provide hope

Weekend reads: immunosuppression & brain cell therapies, big pharma sucking up to Trump, NK cells

Deja ewe: expansive animal cloning raises some difficult questions

Weekend reads: chemical reprogramming, fat precursors, HSCs

Cathy Tie, He Jiankui’s ex-wife, starts ‘Manhattan Project’ to make CRISPR babies

Weekly reads: George Church egg paper, Chinese biotech, stem cells & pleasure, Li & AD

1st George Church retraction: BioViva Rutgers anti-aging paper with Liz Parrish

Recommended reads: direct reprogramming, the road to human embryos from stem cells, Gameto, Church CRISPR interview

Weekly reads: aging clocks easily swayed, OPC1 SCI trial, seesaw as Prasad is back at FDA

Pivot of Nasdaq-traded Celularity highlights tensions & risks from Florida stem cell law

Weekly reads: aging & stem cells, FDA disarray, bad stem cell headline of the week

Why sudden Vinay Prasad departure from FDA is about more than Sarepta missteps

Weekly reads: Sarepta & BrainStorm Cell woes, peptide craze, FDA AI hallucinating